Drug maker BioSyent Pharma has launched its new oral iron supplement, known as FeraMAX Powder, in Canada, which will also mark its international induction. Commenting on the introduction, BioSyent president and CEO René Goehrum ...
BioSyent Pharma, a subsidiary of BioSyent, has signed an exclusive licensing and distribution agreement with an undisclosed European partner for two new products, which will be marketed by its' Hospital Products Division. The two products ...
Tags: BioSyent Pharma, BioSyent, two new products, pharmaceutical products
Specialty pharmaceutical company, BioSyent Inc., said its subsidiary BioSyent Pharma has launched a sterile topical anesthetic called Cathejell Jelly 2% for the Canadian healthcare market. Cathejell Jelly 2% combines a sterile gel and ...
Tags: Sterile Anesthetic, Cathejell Jelly 2%, Canadian healthcare